Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma.
作者信息
Harnois Denise M
出版信息
Mayo Clin Proc. 2012 Jan;87(1):7-8. doi: 10.1016/j.mayocp.2011.11.004.
Abstract
摘要
相似文献
1
Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma.丙型肝炎病毒感染与肝细胞癌发病率的上升。
Mayo Clin Proc. 2012 Jan;87(1):7-8. doi: 10.1016/j.mayocp.2011.11.004.
2
Development of hepatocellular carcinoma in chronic viral B and viral C liver diseases.慢性乙型和丙型病毒性肝病中肝细胞癌的发生
Rom J Gastroenterol. 2003 Jun;12(2):123-30.
3
NASH and HCC.非酒精性脂肪性肝炎与肝细胞癌
Clin Liver Dis. 2009 Nov;13(4):631-47. doi: 10.1016/j.cld.2009.07.007.
4
Prognostic prediction in hepatocellular carcinoma: from art to science.肝细胞癌的预后预测：从艺术到科学。
J Clin Gastroenterol. 2008 Mar;42(3):221-3. doi: 10.1097/MCG.0b013e31815ed0a9.
5
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.质子泵抑制剂与非肝硬化的慢性丙型肝炎感染患者的肝硬化、肝功能失代偿和肝细胞癌的加速发展相关：来自 ERCHIVES 的结果。
Aliment Pharmacol Ther. 2018 Jan;47(2):246-258. doi: 10.1111/apt.14391. Epub 2017 Nov 3.
6
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.在澳大利亚新南威尔士州直接作用抗病毒治疗时代，丙型肝炎病毒相关肝病负担下降。
J Hepatol. 2019 Aug;71(2):281-288. doi: 10.1016/j.jhep.2019.04.014. Epub 2019 May 10.
7
Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand.新西兰慢性丙型肝炎病毒感染所致肝细胞癌患者的监测因素改变了结局。
J Viral Hepat. 2019 Dec;26(12):1372-1376. doi: 10.1111/jvh.13179. Epub 2019 Aug 13.
8
Natural History of Hepatitis C.丙型肝炎的自然史
Gastroenterol Clin North Am. 2015 Dec;44(4):717-34. doi: 10.1016/j.gtc.2015.07.003. Epub 2015 Aug 25.
9
Hepatocellular carcinoma: an emerging problem with hepatitis C.肝细胞癌：丙型肝炎引发的一个新问题。
J Natl Med Assoc. 2000 Aug;92(8):369-71.
10
Hepatitis C: frequency and risk factors associated with sero-positivity among adults in Larkana City.丙型肝炎：拉尔卡纳市成年人血清阳性的频率及相关危险因素。
J Ayub Med Coll Abbottabad. 2009 Apr-Jun;21(2):107-9.
引用本文的文献
1
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study.直接作用抗病毒药物未能降低丙型肝炎病毒相关性肝硬化中肝细胞癌的发生率：一项真实世界研究。
World J Hepatol. 2024 Jan 27;16(1):41-53. doi: 10.4254/wjh.v16.i1.41.
2
Cancer Screening in Refugees and Immigrants: A Global Perspective.难民和移民中的癌症筛查：全球视角
Am J Trop Med Hyg. 2022 May 9;106(6):1593-600. doi: 10.4269/ajtmh.21-0692.
3
Pullulan-coated phospholipid and Pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy.普鲁兰多糖包被的磷脂与普朗尼克F68复合纳米粒用于负载IR780和紫杉醇，通过联合光热疗法/光动力疗法与化疗来治疗肝细胞癌。
Int J Nanomedicine. 2017 Dec 5;12:8649-8670. doi: 10.2147/IJN.S147591. eCollection 2017.
4
Alternative RNA Splicing in the Pathogenesis of Liver Disease.可变RNA剪接在肝脏疾病发病机制中的作用
Front Endocrinol (Lausanne). 2017 Jun 21;8:133. doi: 10.3389/fendo.2017.00133. eCollection 2017.
5
Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma.肝细胞癌中微小RNA与细胞凋亡的关系
Open Access Maced J Med Sci. 2016 Mar 15;4(1):31-7. doi: 10.3889/oamjms.2016.038. Epub 2016 Mar 9.
6
Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.肝细胞癌：从临床实践到循证治疗方案
World J Hepatol. 2015 Sep 18;7(20):2274-91. doi: 10.4254/wjh.v7.i20.2274.
7
TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications.肿瘤坏死因子相关凋亡诱导配体增强丙型肝炎病毒感染致敏的人肝癌细胞的凋亡：治疗意义。
PLoS One. 2014 Jun 13;9(6):e98171. doi: 10.1371/journal.pone.0098171. eCollection 2014.
8
Intra-host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire.科特迪瓦地方性丙型肝炎病毒的宿主内多样性和进化。
J Med Virol. 2014 May;86(5):765-71. doi: 10.1002/jmv.23897. Epub 2014 Feb 12.
9
Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods.利用基于网络的生物信息学方法鉴定肝细胞癌的生物标志物。
Eur J Med Res. 2013 Oct 1;18(1):35. doi: 10.1186/2047-783X-18-35.
本文引用的文献
1
Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.明尼苏达州索马里移民中的病毒性肝炎：丙型肝炎与肝细胞癌的关系。
Mayo Clin Proc. 2012 Jan;87(1):17-24. doi: 10.1016/j.mayocp.2011.08.001.
2
Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008.明尼苏达州奥尔姆斯特德县 1976-2008 年的肝细胞癌。
Mayo Clin Proc. 2012 Jan;87(1):9-16. doi: 10.1016/j.mayocp.2011.07.001.
3
Hepatocellular carcinoma.肝细胞癌
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
4
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.多学科加拿大共识推荐意见：肝细胞癌的管理与治疗。
Curr Oncol. 2011 Oct;18(5):228-40. doi: 10.3747/co.v18i5.952.
5
Management of hepatocellular carcinoma: an update.肝细胞癌的管理：最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
6
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.美国丙型肝炎病毒感染者肝癌监测的利用。
Ann Intern Med. 2011 Jan 18;154(2):85-93. doi: 10.7326/0003-4819-154-2-201101180-00006.
7
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.1975年至2005年美国肝细胞癌的发病率、死亡率及生存趋势
J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.
8
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.
9
Hepatocellular carcinoma in cirrhosis: incidence and risk factors.肝硬化中的肝细胞癌：发病率及危险因素
Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. doi: 10.1053/j.gastro.2004.09.014.
10
Randomized controlled trial of screening for hepatocellular carcinoma.肝细胞癌筛查的随机对照试验
J Cancer Res Clin Oncol. 2004 Jul;130(7):417-22. doi: 10.1007/s00432-004-0552-0.
Zotero 插件